(S)-MCPG,Group I / II mGlu拮抗剂
(S)-MCPG, Group I / II mGlu antagonist
Be the first to review this product! Submit a review
|
(10 Publications)
Group I / II mGluR (metabotropic glutamate receptors) competitive antagonist with some activity reported at mGluR8. MW 209.2.
- Group 1 (mGluR1 and mGluR5 ) and Group 2 (mGluR2 and mGluR3)
- Active isomer of (R,S)-MCPG (ab120033)
- Available in different sizes to fit your experimental needs
查看别名
AMPA-selective glutamate receptor 2, GLUR, GPRC1A, GPRC1B, GRM1-Alpha, GRM1_HUMAN, GRM2_HUMAN, GluR-2, GluR-B, Glutamate metabotropic receptor 2, Glutamate receptor homolog, Glutamate receptor metabotropic 1, Glutamate receptor metabotropic 2, MGLU1, MGLUR2, Metabotropic glutamate receptor 1, Metabotropic glutamate receptor 2, OTTHUMP00000210984, OTTHUMP00000210986, SCAR13, Smp_128940, mGlu2, mGluR1
- Chemical Structure
Lab
Chemical Structure - (S)-MCPG, Group I / II mGlu antagonist (AB120059)
2D chemical structure image of ab120059, (S)-MCPG, Group I / II mGlu antagonist
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - (S)-MCPG, Group I / II mGlu antagonist (AB120059)
ab17722 staining FMRP in SK-N-SH cells treated with (S)-MCPG (ab120059), by ICC/IF. Decrease of FMRP expression correlates with increased concentration of (S)-MCPG, as described in literature.
The cells were incubated at 37°C for 30 minutes in media containing different concentrations of ab120059 ((S)-MCPG) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab17722 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
产品详情
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
文献 (10)
Recent publications for all applications. Explore the full list and refine your search
Proceedings of the National Academy of Sciences of 111:4303-8 PubMed24550458
2014
Applications
Unspecified application
Species
Unspecified reactive species
Neuron 75:58-64 PubMed22794260
2012
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 7:e36397 PubMed22570709
2012
Applications
Unspecified application
Species
Unspecified reactive species
Experimental neurology 233:292-302 PubMed22056941
2011
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychopharmacology : official publication of 36:1811-22 PubMed21508928
2011
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 163:984-94 PubMed21366553
2011
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurophysiology 104:3413-23 PubMed20861429
2010
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of physiology 588:1499-514 PubMed20211977
2010
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 30:3398-408 PubMed20203199
2010
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 30:1471-5 PubMed20107074
2010
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com